Outlook Wealth Advisors, LLC Abb Vie Inc. Transaction History

Outlook Wealth Advisors, LLC

$288 Million
Q3 2024

A detailed history of Outlook Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Outlook Wealth Advisors, LLC holds 1,231 shares of ABBV stock, worth $209,700. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,231

Previous 1,193 3.19%

Holding current value

$209,700

Previous $204,000 19.12%

% of portfolio

0.08%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $6,225 - $7,574	38 Added 3.19%	1,231 $243,000
Q2 2024 Jul 18, 2024	SELL	$154.79 - $180.76 $7,739 - $9,038	-50 Reduced 4.02%	1,193 $204,000
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $65,206 - $74,296	-408 Reduced 24.71%	1,243 $226,000
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $11,833 - $13,327	86 Added 5.5%	1,651 $255,000
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $207,378 - $258,068	1,565 New	1,565 $210,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2,766 - $3,317	-20 Reduced 1.28%	1,540 $249,000
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $3,489 - $4,002	-26 Reduced 1.64%	1,560 $210,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $2,614 - $3,324	-19 Reduced 1.18%	1,586 $243,000
Q1 2022 Jul 28, 2022	BUY	$131.98 - $163.75 $211,827 - $262,818	1,605 New	1,605 $261,000
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $207,503 - $280,151	-2,578 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $50,257 - $58,985	-585 Reduced 18.5%	2,578 $226,000
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $99,489 - $133,132	-1,356 Reduced 30.01%	3,163 $311,000
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $57,211 - $86,739	-887 Reduced 16.41%	4,519 $344,000
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $329,994 - $412,893	-4,575 Reduced 45.84%	5,406 $479,000
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $30,734 - $36,951	488 Added 5.14%	9,981 $756,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $46,187 - $59,037	703 Added 8.0%	9,493 $690,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $588,732 - $692,909	7,632 Added 659.07%	8,790 $708,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $90,150 - $111,179	1,158 New	1,158 $1.07 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Outlook Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Outlook Wealth Advisors, LLC with notifications on news.

Account

Outlook Wealth Advisors, LLC Abb Vie Inc. Transaction History